Playlist


Gurbanguly Berdimuhamedov Congratulates Amangozel Shaguliyeva on Her 85th Birthday
12 Aug. 06:03National Leader of the Turkmen people and Chairman of the Halk Maslahaty of Turkmenistan, Gurbanguly Berdimuhamedov, sent a congratulatory letter to Amangozel Shaguliyeva, Hero of Turkmenistan and People’s Poet, on her 85th birthday, TDH reports.
In the letter, he noted that the country's historical transformations and international achievements are widely reflected in the works of writers, poets, and journalists, with Shaguliyeva’s creativity playing a special role.
Berdimuhamedov emphasized that her poetry is regularly featured in the press, on television, and radio, earning her deep respect among the people. He also mentioned that her work was reflected in his book "The Meaning of My Life," where he highlighted her contributions to Turkmen literature and the country’s cultural and public life.
He wrote that her verses express profound love for the homeland, loyalty to ancestral traditions, the noble qualities of Turkmen women, and the importance of child upbringing.
The letter also pointed out that her 85th anniversary coincides with the grand celebration of the 30th anniversary of Turkmenistan’s permanent neutrality. In Turkmen tradition, the age of 85 is considered a symbol of wisdom, dignity, and maturity.
Amangozel Shaguliyeva has been awarded the title “Hero of Turkmenistan,” the honorary title “People’s Writer of Turkmenistan,” the Magtymguly International Prize, and numerous other state awards.
Also read


Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.